日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A New Approach to Cancer Second Opinions: Overcoming the Challenges of Conventional Oncology Practice by Providing Education to Patients and Physicians

癌症二次诊疗意见新方法:通过向患者和医生提供教育来克服传统肿瘤学实践中的挑战

Barrett, William L; Leming, Philip D; Hunt, Jillian; Guinigundo, Andrew; Uhrig, Lana; Zon, Robin; Jazieh, Abdul R

Precision Oncology and the Evolution of Breast Cancer Care

精准肿瘤学与乳腺癌治疗的演变

Guinigundo, Andrew S

A Systematic Approach to Optimize the Implementation of Precision Oncology in Clinical Practice: A Meeting Proceeding

优化精准肿瘤学在临床实践中实施的系统方法:会议论文集

Jazieh, Abdul Rahman; El Rouby, Nihal; Guinigundo, Andrew; Huelsman, Karen M; Curran, Emily; Khan, Rafiullah; Grund, Jaime; Calvo, Alejandro R; Claes, Jason J; Overton, Sarah C; Hellard, Sally; Vasiliadis, Leah; Liu, Minetta; Blaxall, Burns C

Staying Abreast of New Biomarkers in Hematology/Oncology

密切关注血液学/肿瘤学领域的新生物标志物

Guinigundo, Andrew; Baek, Grace

The Advanced Practitioner's Role in the Rapidly Evolving Landscape of Precision Medicine

高级执业医师在快速发展的精准医疗领域中的作用

Moore, Donald C; Guinigundo, Andrew S

The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology

生物标志物在指导肿瘤临床决策中的作用

Moore, Donald C; Guinigundo, Andrew S

Uncovering and Addressing Implicit Bias in Oncology

揭示和解决肿瘤学中的隐性偏见

Dimarco, Rose; Guinigundo, Andrew S; Valdueza, Caressa

NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim

NOLAN:一项随机、II期研究,旨在评估预防性使用萘普生或氯雷他定与不进行预防性治疗相比,对接受化疗和培非格司亭治疗的早期乳腺癌患者骨痛的影响。

Kirshner, Jeffrey J; McDonald, Maxwell C 3rd; Kruter, Flavio; Guinigundo, Andrew S; Vanni, Linda; Maxwell, Cathy L; Reiner, Maureen; Upchurch, Terry E; Garcia, Jacob; Morrow, Phuong Khanh